A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in ...

Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.

Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the recombinant shingles vaccine (Shingrix) -- were tied to a lower dementia risk, an ...